Cargando…

Access to essential medicines and standard treatment for chronic diseases

Detalles Bibliográficos
Autor principal:	Kotwani, Anita
Formato:	Texto
Lenguaje:	English
Publicado:	Medknow Publications 2010
Materias:	Editorial
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2937310/ https://www.ncbi.nlm.nih.gov/pubmed/20871760 http://dx.doi.org/10.4103/0253-7613.66830

Ejemplares similares

Where are we now: assessing the price, availability and affordability of essential medicines in Delhi as India plans free medicine for all
por: Kotwani, Anita
Publicado: (2013)

Psychiatric medicines in India: why public healthcare facilities and a thriving generics industry cannot assure access and affordability
por: Kotwani, Anita
Publicado: (2012)

Gaps in access to essential medicines and health products for noncommunicable diseases and mental health conditions
por: Minghui, Ren, et al.
Publicado: (2020)

Access to antibiotics in New Delhi, India: implications for antibiotic policy
por: Kotwani, Anita, et al.
Publicado: (2013)

Need to improve availability of “access” group antibiotics and reduce the use of “watch” group antibiotics in India for optimum use of antibiotics to contain antimicrobial resistance
por: Gandra, Sumanth, et al.
Publicado: (2019)

Medicinal Plants in the Prevention and Treatment of Chronic Diseases
por: Eddouks, Mohamed, et al.
Publicado: (2012)

Open Access to essential health care information
por: Stokes, Christabel EL, et al.
Publicado: (2004)

Medicinal Plants in the Prevention and Treatment of Chronic Diseases 2013
por: Eddouks, Mohamed, et al.
Publicado: (2014)

Open science, open access and open source software at Open Medicine
por: Murray, Sally, et al.
Publicado: (2008)

Free access to medicines for the treatment of chronic diseases in Brazil
por: Tavares, Noemia Urruth Leão, et al.
Publicado: (2016)

Using health markets to improve access to medicines: three case studies
por: Shroff, Zubin, et al.
Publicado: (2016)

Medicine Use in Chronic Diseases
por: Unni, Elizabeth
Publicado: (2023)

Collaborative partnerships as a solution for poor access to essential antimicrobial medicines: what can we learn from the chlorhexidine gel example?
por: Tack, Bieke, et al.
Publicado: (2022)

Making diagnostic tests as essential as medicines
por: Velazquez Berumen, Adriana, et al.
Publicado: (2018)

WHO essential medicines for reproductive health
por: Gill, Roopan, et al.
Publicado: (2019)

Concept of essential medicines and recent updates
por: Gupta, Shreya, et al.
Publicado: (2023)

Access to medicines for rare diseases: beating the drum for primary ciliary dyskinesia
por: Crowley, Suzanne, et al.
Publicado: (2020)

Noncommunicable diseases, access to essential medicines and universal health coverage
por: Beran, David, et al.
Publicado: (2019)

Regenerative Medicine Research: an open access translational medicine journal
por: Kang, Y James
Publicado: (2013)

Natural Products for the Prevention and Treatment of Chronic Inflammatory Diseases: Integrating Traditional Medicine into Modern Chronic Diseases Care
por: Kim, Ji Hye, et al.
Publicado: (2018)

The access and waiting-time standard for first-episode psychosis: an opportunity for identification and treatment of psychosis risk states?
por: Whale, Richard, et al.
Publicado: (2017)

A comparative evaluation of price and quality of some branded versus branded–generic medicines of the same manufacturer in India
por: Singal, G.L., et al.
Publicado: (2011)

Back to the ‘essence’ of medical treatment in oncology: the 2015 WHO Model List of Essential Medicines
por: Eniu, Alexandru, et al.
Publicado: (2016)

Patent pooling to increase access to essential medicines
por: Burrone, Esteban, et al.
Publicado: (2019)

Access and use of WHO essential medicines in Italy
por: Petrella, Alessandro, et al.
Publicado: (2023)

Equity of Access to Quality of Care in Family Medicine
por: Harris, M. F., et al.
Publicado: (2011)

Welcome to Tropical Medicine and Infectious Disease—A New Era in Open Access Publication
por: Leggat, Peter A., et al.
Publicado: (2016)

Occupational Medicine and Prevention of Chronic and Infectious Diseases
por: La Torre, Giuseppe, et al.
Publicado: (2023)

Towards Personalized Medicine for Chronic Liver Disease
por: Gao, Jingwen, et al.
Publicado: (2023)

Crisis Standards of Care for the COVID-19 Pandemic: An Essential Resource for the PALTC Community
por: Wright, Jim
Publicado: (2021)

Balancing intellectual monopoly privileges and the need for essential medicines
por: Martin, Greg, et al.
Publicado: (2007)

Medicine in the time of corona: Fundamental molecular research is “essential”
por: Shilatifard, Ali
Publicado: (2020)

Essential role of medicine and food homology in health and wellness
por: Chen, Junshi
Publicado: (2023)

Expensive medicines: ensuring objective appraisal and equitable access
por: Hill, Suzanne R, et al.
Publicado: (2015)

Phytochemical Constituents of Medicinal Plants for the Treatment of Chronic Inflammation
por: Kang, Ki Sung
Publicado: (2021)

The Phytochemical Constituents of Medicinal Plants for the Treatment of Chronic Inflammation
por: Kim, Young-Joo, et al.
Publicado: (2023)

Essential medicines for children: Should we focus on a priority list of medicines for the present?
por: Gitanjali, B
Publicado: (2011)

Could Nitazoxanide Be Added to Other Essential Medicines for Integrated Neglected Tropical Disease Control and Elimination?
por: Hotez, Peter J.
Publicado: (2014)

Access to Essential Medicines and Diagnostic Tests for Cardiovascular Diseases in Maputo City, Mozambique
por: Jessen, Neusa, et al.
Publicado: (2023)

Are we moving towards a new definition of essential medicines?
por: Manikandan, S
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_4582cjqiuenj5lh5422l9gtt7e